List of Saladax Biomedical patents

Patents where

Current Assignee

Name

Saladax Biomedical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11385246 Antibodies to paliperidone and use thereof		Saladax Biomedical	Saladax Biomedical	United States Patent and Trademark Office	11385246	July 12, 2022
‌ US Patent 7276347 Cytoxan antibodies and immunoassay	Patent 7276347 was granted and assigned to Saladax Biomedical on October, 2007 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7276347	October 2, 2007
‌ US Patent 7459281 Docetaxel immunoassay	Patent 7459281 was granted and assigned to Saladax Biomedical on December, 2008 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7459281	December 2, 2008
‌ US Patent 7175993 Taxol immunoassay	Patent 7175993 was granted and assigned to Saladax Biomedical on February, 2007 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7175993	February 13, 2007
‌ US Patent 7423131 Busulfan immunoassay	Patent 7423131 was granted and assigned to Saladax Biomedical on September, 2008 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7423131	September 9, 2008
‌ US Patent 8076097 Imatinib immunoassay	Patent 8076097 was granted and assigned to Saladax Biomedical on December, 2011 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8076097	December 13, 2011
‌ US Patent 8450461 Risperidone immunoassay	Patent 8450461 was granted and assigned to Saladax Biomedical on May, 2013 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8450461	May 28, 2013
‌ US Patent 8114621 Lenalidomide and thalidomide immunoassays	Patent 8114621 was granted and assigned to Saladax Biomedical on February, 2012 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8114621	February 14, 2012
‌ US Patent 9551724 5-fluoro-uracil immunoassay	Patent 9551724 was granted and assigned to Saladax Biomedical on January, 2017 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	9551724	January 24, 2017
‌ US Patent 8426143 Gemcitabine immunoassay	Patent 8426143 was granted and assigned to Saladax Biomedical on April, 2013 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8426143	April 23, 2013
‌ US Patent 8053205 Doxorubicin immunoassay	Patent 8053205 was granted and assigned to Saladax Biomedical on November, 2011 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8053205	November 8, 2011
‌ US Patent 8039220 Stabilized standards for busulfan immunoassay	Patent 8039220 was granted and assigned to Saladax Biomedical on October, 2011 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8039220	October 18, 2011
‌ US Patent 8771972 Clozapine immunoassay	Patent 8771972 was granted and assigned to Saladax Biomedical on July, 2014 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8771972	July 8, 2014
‌ US Patent 10823739 Immunoassay standards and measurement of tau using intra-assay calibration standards	Patent 10823739 was granted and assigned to Saladax Biomedical on November, 2020 by the United States Patent and Trademark Office.	Saladax Biomedical	Saladax Biomedical	United States Patent and Trademark Office	10823739	November 3, 2020
‌ US Patent 7569358 Doxorubicin immunoassay	Patent 7569358 was granted and assigned to Saladax Biomedical on August, 2009 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7569358	August 4, 2009
‌ US Patent 7148024 Busulfan immunoassay	Patent 7148024 was granted and assigned to Saladax Biomedical on December, 2006 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7148024	December 12, 2006
‌ US Patent 8946392 Gemcitabine immunoassay	Patent 8946392 was granted and assigned to Saladax Biomedical on February, 2015 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8946392	February 3, 2015
‌ US Patent 7893220 Busulfan immunoassay	Patent 7893220 was granted and assigned to Saladax Biomedical on February, 2011 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7893220	February 22, 2011
‌ US Patent 7300768 Enzymatic measurement of imatinib mesylate	Patent 7300768 was granted and assigned to Saladax Biomedical on November, 2007 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7300768	November 27, 2007
‌ US Patent 7767794 5-fluoro-uracil immunoassay	Patent 7767794 was granted and assigned to Saladax Biomedical on August, 2010 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	7767794	August 3, 2010
‌ US Patent 10670612 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards		Saladax Biomedical	Saladax Biomedical	United States Patent and Trademark Office	10670612	June 2, 2020
‌ US Patent 8293492 Lenalidomide and thalidomide immunoassays	Patent 8293492 was granted and assigned to Saladax Biomedical on October, 2012 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8293492	October 23, 2012
‌ US Patent 8329416 Stabilized standards for busulfan immunoassay	Patent 8329416 was granted and assigned to Saladax Biomedical on December, 2012 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8329416	December 11, 2012
‌ US Patent 8084586 Doxorubicin immunoassay	Patent 8084586 was granted and assigned to Saladax Biomedical on December, 2011 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8084586	December 27, 2011
‌ US Patent 8088594 Risperidone immunoassay	Patent 8088594 was granted and assigned to Saladax Biomedical on January, 2012 by the United States Patent and Trademark Office.		Saladax Biomedical	United States Patent and Trademark Office	8088594	January 3, 2012

Results per page:

28 results

0 selected

28 results

0 selected